# Pharmstandard: portfolio, investments and team > Pharmstandard is a corporate vc. 8 investments on record, latest Dec 2017. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/pharmstandard (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # Pharmstandard Last cheque observed Dec 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Corporate VC Series B Series D Series E Biotechnology Manufacturing Pharmaceutical Cheques on record **0%** of best year **0** **cheques in 12 months**, 8 on record Since the last cheque **3241** days **00** hrs **00** min **00** sec Median round **$21M** Rounds led **0 of 8** Sole investor **1 rounds** Mostly in **United States, 75%** Pitch Pharmstandard ## Pharmstandard highlights - 01 8 rounds on record - 02 Mostly Series B and Series D: 86% of its rounds - 03 Sole investor in 1 rounds, median $4.0M ## What they do - **Type:** Corporate VC (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Biotechnology Manufacturing Pharmaceutical - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **8 appearances** - **2017** 2 rounds - **Dec** **[OncoTartis](https://millionrounds.com/company/oncotartis)** US · FinSMEs **$6.0M** With 1 other - **Dec** **[Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics)** Series B · US · FinSMEs **$36M** With 8 others - **2015** 2 rounds - **Apr** **[Jounce Therapeutics](https://millionrounds.com/company/jounce-therapeutics)** Series B · US **$56M** With 7 others - **Jan** **[enGene](https://millionrounds.com/company/engene)** Series B · CA **$12M** With 2 others - **2014** 2 rounds - **Dec** **[Allena Pharmaceuticals](https://millionrounds.com/company/allena-pharmaceuticals)** Series B · US **$25M** With 4 others - **May** **[Proteon Therapeutics](https://millionrounds.com/company/proteon-therapeutics)** Series D · US **$45M** With 9 others - **2013** 2 rounds - **Sept** **[Protagonist Therapeutics](https://millionrounds.com/company/protagonist-therapeutics)** Series B · AU · pevc.dowjones.com **$4.0M** Sole investor - **Aug** **[Argos Therapeutics](https://millionrounds.com/company/argos-therapeutics)** Series E · US · finsmes.com **$43M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## What they claim to have backed From their own portfolio page (on their website) **0** of 2 we have independently watched raise Disclosure of information Ph2014 Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## The cheque Series B Series D Series E Median round joined **$21M** the round, not its cheque Alone, median **$4.0M** Led 0 of 8 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Dec 2017 Rounds by stage said on their site - Series B *5* - Series D *1* - Series E *1* Cheques by year Led Joined 2013 2017 Often in the room with - [Bessemer Venture Partners](https://millionrounds.com/fund/bessemer-venture-partners) 2 - [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 2 - [Intersouth Partners](https://millionrounds.com/fund/intersouth-partners) 2 - [Nextech Invest](https://millionrounds.com/fund/nextech-invest) 2 - [Wellington Management](https://millionrounds.com/fund/wellington-management) 2 **Pitching Pharmstandard?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Pharmstandard. A count of rooms they were both in, not a relationship either has claimed. [**Bessemer Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/bessemer-venture-partners)[**Casdin Capital** VC firm **2** rounds together](https://millionrounds.com/fund/casdin-capital)[**Intersouth Partners** VC firm **2** rounds together](https://millionrounds.com/fund/intersouth-partners)[**Nextech Invest** Private equity **2** rounds together](https://millionrounds.com/fund/nextech-invest)[**Wellington Management** VC firm **2** rounds together](https://millionrounds.com/fund/wellington-management) ## Quick answers about Pharmstandard ### What does Pharmstandard invest in? Pharmstandard invests most often at Series B and Series D (86% of the rounds on record), in sectors such as Biotechnology, Manufacturing and Pharmaceutical. ### How active is Pharmstandard? 8 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2017. ### What has Pharmstandard invested in recently? Its most recent investments on record: OncoTartis (Undisclosed round, Dec 2017) and Neon Therapeutics (Series B, Dec 2017). ### How big are Pharmstandard's cheques? The median round it joins is $21M. ### Does Pharmstandard lead rounds? Rarely, if at all: none of its 8 investments on record names it as the lead. ### Where does Pharmstandard invest? Most of the companies it backs are in the United States (75%), Canada (13%) and Australia (13%). ### Is Pharmstandard investing now? No investments in the last 12 months; the latest was in Dec 2017. ### Who does Pharmstandard invest alongside? Most often Bessemer Venture Partners (2 rounds together), Casdin Capital (2 rounds together) and Intersouth Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=pharmstandard) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=pharmstandard)